Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA Study.
Kiltz U, Sfikakis PP, Gaffney K, Sator PG, von Kiedrowski R, Bounas A, Gullick N, Conrad C, Rigopoulos D, Lespessailles E, Romanelli M, Ghislain PD, Brandt-Jürgens J, Rashkov R, Aassi M, Orsenigo R, Perella C, Pournara E, Gathmann S, Jagiello P, Veit J, Augustin M. Kiltz U, et al. Among authors: gathmann s. Adv Ther. 2020 Jun;37(6):2865-2883. doi: 10.1007/s12325-020-01352-8. Epub 2020 May 6. Adv Ther. 2020. PMID: 32378070 Free PMC article.
Baseline characteristics of patients with moderate-to-severe psoriasis according to previous systemic treatment exposure: the PROSE study population.
Augustin M, Dauden E, Mrowietz U, Konstantinou MP, Gerdes S, Rissler M, Gathmann S, Sieder C, Baeumer D, Orsenigo R. Augustin M, et al. Among authors: gathmann s. J Eur Acad Dermatol Venereol. 2020 Nov;34(11):2548-2556. doi: 10.1111/jdv.16400. Epub 2020 May 20. J Eur Acad Dermatol Venereol. 2020. PMID: 32239541
Secukinumab treatment leads to normalization of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: the PROSE study results.
Augustin M, Dauden E, Mrowietz U, Konstantinou MP, Gerdes S, Kingo K, Szepietowski JC, Perrot JL, Cuccia A, Rissler M, Gathmann S, Sieder C, Orsenigo R, Jagiello P, Bachhuber T. Augustin M, et al. Among authors: gathmann s. J Eur Acad Dermatol Venereol. 2021 Feb;35(2):431-440. doi: 10.1111/jdv.16632. Epub 2020 Jul 1. J Eur Acad Dermatol Venereol. 2021. PMID: 32426889
Platinum Graphene Catalytic Condenser for Millisecond Programmable Metal Surfaces.
Onn TM, Gathmann SR, Guo S, Solanki SPS, Walton A, Page BJ, Rojas G, Neurock M, Grabow LC, Mkhoyan KA, Abdelrahman OA, Frisbie CD, Dauenhauer PJ. Onn TM, et al. Among authors: gathmann sr. J Am Chem Soc. 2022 Dec 7;144(48):22113-22127. doi: 10.1021/jacs.2c09481. Epub 2022 Nov 16. J Am Chem Soc. 2022. PMID: 36383403
Alumina Graphene Catalytic Condenser for Programmable Solid Acids.
Onn TM, Gathmann SR, Wang Y, Patel R, Guo S, Chen H, Soeherman JK, Christopher P, Rojas G, Mkhoyan KA, Neurock M, Abdelrahman OA, Frisbie CD, Dauenhauer PJ. Onn TM, et al. Among authors: gathmann sr. JACS Au. 2022 May 7;2(5):1123-1133. doi: 10.1021/jacsau.2c00114. eCollection 2022 May 23. JACS Au. 2022. PMID: 35647588 Free PMC article.
11 results